CLOVER HEALTH INVESTMENTS, CORP. /DE 8-K

What Happened
Clover Health Investments, Corp. announced on May 18, 2026 that it published written responses to a selection of frequently asked supplemental questions submitted in connection with the company's first quarter 2026 earnings announcement. The responses were furnished to the SEC as Exhibit 99.1 to the Form 8‑K and posted on Clover Health’s investor relations website. The filing is reported under Item 7.01 (Regulation FD Disclosure).

Key Details

• Date filed: May 18, 2026 (Form 8‑K accession 0001801170-26-000128).
• Content: Supplemental FAQ responses related to Clover’s Q1 2026 earnings announcement, furnished as Exhibit 99.1.
• Availability: The FAQ responses are included in the 8‑K and available on the company’s investor relations webpage.
• Signature: Form 8‑K signed by Clay Thornton, Interim Chief Financial Officer (Principal Financial Officer).

Why It Matters
This Regulation FD disclosure provides additional, company‑approved answers to investor questions about Clover’s Q1 2026 quarterly results, offering clarity directly from management. For retail investors, the FAQ may clarify results, metrics, or near‑term priorities discussed in the earnings release and can be used alongside the earnings report and other filings when evaluating the company.